Global Cell Therapy Market – Industry Trends & Forecast to 2026

Market Definition: Global Cell Therapy Market
Cell therapy is known as a type of therapy in which live cells are injected into a patient for the treatment of a number of disorders. For example, T-Cells are injected for the treatment of cancer as they are capable of fighting cancer cells during the immunotherapy treatment course.
Market Analysis: Global Cell Therapy Market
Global cell therapy market is expected to rise from its initial estimated value of USD 5.52 billion in 2018 to an estimated value of USD 8.70 billion by 2026, registering a CAGR of 5.85% in the forecast period of 2019-2026. This rise in market value can be attributed to the increasing investments and funding from government and private institutions.
Segmentation: Global Cell Therapy Market
- By Type
- Autologous
- Allogeneic
- By Technology
- Somatic Cell Technology
- Cell Immortalization Technology
- Viral Vector Technology
- Ex-Vivo Gene Modification
- In-Vivo Gene Modification
Key Market Competitors: Global Cell Therapy Market
Few of the major competitors currently working in the cell therapy market are Vericel, Kolon TissueGene Inc., JCR Pharmaceuticals Co. Ltd., MEDIPOST, Osiris, Stemedica Cell Technologies Inc., NuVasive Inc., Fibrocell Science Inc., Cellectis, BioNTech IMFS, pluristem, Grupo Praxis, Genzyme Corporation, Advanced Tissue, Cells for Cells, PHARMICELL Co. Ltd, ANTEROGEN.CO.LTD., Novartis AG, GlaxoSmithKline plc, CELGENE CORPORATION, Bone Therapeutics, Cell Therapies, Celyad, Regen BioPharma, Cellular Therapeutics Ltd, TxCell, and Advancells.
CONTACT US:
Customer Support 24*7
USA Number – +1 888 387 2818 (Toll – Free)
Europe Number – +44 208 089 1725
Asia Pacific Number – +81 34 520 8959
Skype.Address: databridgemarketresearch
Website :https://databridgemarketresearch.com
Comments
Post a Comment